A simple and effective method for protecting newborns from HIV has been the focus of recent research. Currently, the risk of transmitting HIV from mother to child can be significantly reduced through the use of antiretroviral drugs during pregnancy and childbirth, or by performing a caesarean section to avoid exposure to cervical and vaginal fluids that may contain the virus. Despite these precautions, there is still a small chance—less than 1 percent—that a child could become infected. In such cases, the child would typically require lifelong antiviral therapy to manage the virus and prevent its progression. While there are more aggressive options, such as bone marrow or stem cell transplants, which can potentially eliminate the virus, these treatments are expensive, risky, and not always successful. As a result, scientists have been searching for safer and more accessible alternatives to help children who are infected at birth. In a surprising discovery, researchers from the University of Health and Science in Oregon, United States, may have found a promising new approach. On August 10, 2026, their findings were published in the journal Nature Microbiology, describing a triple treatment administered shortly after birth that completely eliminated the virus in macaques—non-human primates often used in medical research due to their genetic similarity to humans. This treatment could represent a major breakthrough in the fight against perinatal HIV transmission. The study suggests that this new method could offer a more practical and economical solution compared to existing treatments. If successful in human trials, it could significantly reduce the long-term health burdens faced by children born with HIV and offer hope for a cure that is both accessible and effective.